Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment.

CNS neuroscience & therapeutics - 1 Feb 2014

Lin Yong-Juan, Li Jing-Wei, Zhang Mei-Juan, Qian Lai, Yang Wen-Jie, Zhang Chun-Lei, Shao Yuan, Zhang Yang, Huang Yu-Jie, Xu Yun

Abstract excerpt

AIMS: Preventing stroke through endovascular treatment with vertebral artery stent remains a great challenge due to the occurrence of an in-stent restenosis. MATERIALS & METHODS: In this study, a retrospective analysis was conducted in 90 patients who had been treated with VAS between 2004 and 20...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Logistic Models

Share to Longitudinal Studies

Share to Stents

Share to Treatment Outcome

Share to Vascular Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 24330577
DOI: 10.1111/cns.12173
PMCID: PMC6493190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24330577-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment.PMID 24330577Read ↗

Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis.Semantic proximity Read ↗

CYP2C19⁎2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.Semantic proximity Read ↗

[Influence of CYP2C19 gene polymorphisms on the efficacy of clopidogrel treatment for the prevention of ischemic stroke following coronary stent implantation].Semantic proximity Read ↗

Impact of Total Protein Level and Dysglycaemia on the Efficacy of Clopidogrel in Patients Underwent Carotid Artery Stenosis with CYP2C19 Genetic VariantsSemantic proximity Read ↗

Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery Stenting.Semantic proximity Read ↗

CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: A matched case-control studySemantic proximity Read ↗

Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia.Semantic proximity Read ↗

CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: a matched case-control study.Semantic proximity Read ↗

Relationship of paraoxonase-1 Q192R genotypes and in-stent restenosis and re-stenting in Chinese patients after coronary stenting.Semantic proximity Read ↗

CYP2C19 polymorphism and clinical outcomes of patients with carotid artery stentingSemantic proximity Read ↗

CYP2C19 Genotype-Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure.Semantic proximity Read ↗

Genetic variability in stroke patients: CYP2C19 polymorphisms unraveled.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.